Morgan Stanley Novo Nordisk A S Put Options Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.42 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.12 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$935 Million1.24% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$896 Million0.36% of portfolio
-
Fayez Sarofim & CO Houston, TX11.2MShares$846 Million2.01% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $170B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...